Skin & aging Neurotransmitter-inhibiting peptide
Pentapeptide-18
Regulatory status
Status at a glance
503A compounding status
Not nominated
We found no pending nomination for the 503A bulks list. Unless the substance has another legal pathway (for example, a USP monograph or use in an FDA-approved drug), 503A pharmacies generally may not compound with it.
- FDA approval
- Not FDA-approved for any use
- 503B outsourcing
- Not determined
- Anti-doping (WADA)
- Not on the WADA Prohibited List
- DEA schedule
- Not a controlled substance
About peptide status
Most peptides discussed here are not FDA-approved for any use, and products labeled “research use only” are not for human use. Removal from Category 2 does not authorize compounding. PCAC votes are non-binding recommendations; FDA and HHS make the final decisions.
This is not medical or legal advice, and we do not publish dosing, sourcing or reconstitution information. Talk with a licensed clinician before using any peptide.
If you think you are having a medical emergency, call 911.
Key takeaway
Pentapeptide-18 is a synthetic five-amino acid peptide, sold as Leuphasyl, used in skincare to target expression lines. Laboratory work suggests it mimics a natural "calming" messenger that reduces the release of the neurotransmitter that triggers muscle contraction, which is the basis for its use in products aimed at the look of dynamic wrinkles. As of 2026, the support is laboratory and manufacturer data, with human testing done only inside combination formulas rather than on the peptide alone.
At a glance
- What it is
- Cosmetic ingredient, a neuro-inspired "expression line" peptide (sold as Leuphasyl)
- FDA status
- Does not require FDA approval, as a cosmetic ingredient rather than a drug
- Research
- Activity rests on laboratory and manufacturer data; human evidence comes from combination formulas
- Used in
- "Anti-aging" products for the look of expression lines, often alongside Argireline
- Evidence strength
- Low research
Summary
Pentapeptide-18 (Leuphasyl) is a cosmetic peptide used for the look of expression lines. Learn how it works, where it is used, and how strong the evidence is.
What is pentapeptide-18?
Pentapeptide-18 is a synthetic peptide of five amino acids, modeled on enkephalin, one of the body's natural signaling peptides. It is made by Lipotec under the trade name Leuphasyl and is used in skincare aimed at the appearance of expression lines. It is a cosmetic ingredient, not a drug, and is often paired with other "expression line" peptides.
How does it work?
Laboratory studies describe pentapeptide-18 as a peptide that quiets the signal driving muscle contraction, but at an earlier step than some related peptides. The proposed mechanism runs in steps:
- As an enkephalin mimic, it binds receptors on the nerve ending.
- Those receptors in turn reduce the inflow of calcium.
- Because calcium is needed to release acetylcholine, the neurotransmitter that tells muscle to contract, less acetylcholine is released.
- The small muscles that form expression lines contract less.
It is marketed as working in tandem with Argireline, which acts at a different point in the same release pathway.
These are laboratory and manufacturer findings, and a topical cosmetic does not reach or paralyze muscle the way an injection does. In finished products the benefit is described in appearance terms, the look of softer, smoother expression lines.
Is it FDA-approved?
Safety note
Status: Does not require FDA approval, as a cosmetic ingredient rather than a drug
Category: Cosmetic and topical · Primary body area: Skin & aging
No, and it does not need to be. The FDA does not pre-approve cosmetic ingredients. A cosmetic may describe effects on the appearance of skin, while a claim to relax muscles or change the body's function would make a product a drug. Pentapeptide-18 is used as a cosmetic ingredient, for the appearance of the skin.
What is it used for?
Pentapeptide-18 is used in "anti-aging" serums and creams aimed at dynamic or expression lines, such as forehead lines and crow's-feet. The appearance goal is smoother-looking skin and a reduction in the look of movement-related lines. It is frequently combined with acetyl hexapeptide-8 (Argireline) and other actives.
What does the research show?
Editor’s note
Evidence strength: Low research
The peptide-specific evidence is computational and laboratory-based, and the human data come only from combination formulas, so there is no sound human evidence for the ingredient on its own.
The direct evidence for the isolated peptide is limited. According to PubMed, the peptide-specific research is largely computational and laboratory work, such as a modeling study of how it interacts with its target. Where it has been tested on people, it has been combined with other actives, for example within retinol-loaded formulations, so the effect cannot be attributed to pentapeptide-18 alone. No independent human trial of the ingredient by itself was found.
What are the side effects?
Pentapeptide-18 is generally reported as well tolerated on the skin, with low irritation potential at cosmetic use levels, and topical use is not known to produce a systemic nerve or muscle effect. Independent safety data are limited, so a patch test is reasonable for sensitive skin.
Sources: a molecular modeling study of pentapeptide-18 (Akhan et al., Computational Biology and Chemistry, 2026, DOI: 10.1016/j.compbiolchem.2026.108952); and a study of retinol-and-peptide formulations tested on volunteers (Pawłowska et al., Life, 2024, DOI: 10.3390/life14101212), both indexed on PubMed. This document is educational and does not constitute medical advice.
Registered human trials
0 registered human trials on ClinicalTrials.gov that we reviewed
Sources
- [1]
- [2]
- [3]
- [4]
Compare every peptide’s status in the peptide regulatory status database
More for Skin & aging
View all skin & aging peptides →- Cosmetic & topical Skin & aging
Acetyl-Hexapeptide-8
Argireline
Acetyl hexapeptide-8, sold in skincare as Argireline, is a synthetic peptide modeled on the nerve protein SNAP-25 and marketed as a topical, "Botox-like" way to soften the appearance of expression lines. In lab and small clinical studies it interferes with the SNARE complex that nerves use to trigger muscle contraction, and a 2013 randomized study found it reduced the appearance of peri-orbital wrinkles over four weeks. It is a cosmetic ingredient rather than a drug, so it does not require FDA approval, and its evidence is rated Moderate.
- Cosmetic & topical Skin & aging
Acetyl-Octapeptide-3
SNAP-8
Acetyl octapeptide-3, sold in skincare as SNAP-8, is a synthetic eight-amino acid peptide modeled on the nerve protein SNAP-25 and marketed as a stronger successor to Argireline for softening the appearance of expression lines. Like Argireline, it is designed to interfere with the SNARE complex that nerves use to trigger muscle contraction, but its own published human evidence is thin and comes mostly from the manufacturer. It is a cosmetic ingredient rather than a drug, so it does not require FDA approval, and its evidence is rated Low.
- Cosmetic & topical Skin & aging
Acetyl-Tetrapeptide-5
Eyeseryl
Acetyl tetrapeptide-5, sold in skincare as Eyeseryl, is a synthetic four-amino acid peptide used in eye creams to soften the look of under-eye bags and puffiness. It is thought to work in two ways, by easing the fluid buildup that makes the under-eye area look swollen and by limiting the glycation that stiffens collagen, though its published evidence comes almost entirely from the manufacturer. It is a cosmetic ingredient rather than a drug, so it does not require FDA approval, and its evidence is rated Low.
- FDA-approved Skin & aging
Afamelanotide
Afamelanotide is a synthetic, longer-lasting analog of alpha-melanocyte-stimulating hormone (α-MSH) that activates the MC1R receptor on pigment cells to boost the skin's own protective eumelanin. The FDA approved it in 2019 as Scenesse, a subcutaneous implant for adults with erythropoietic protoporphyria (EPP), a rare light-sensitivity disorder. In the pivotal 2015 placebo-controlled trials, U.S. patients (94) logged a median 69.4 pain-free hours in direct sunlight versus 40.8 on placebo (P = 0.04). EU patients (74) logged 6.0 versus 0.8 hours (P = 0.005).
- FDA-approved Skin & aging
Bacitracin
Bacitracin is a cyclic polypeptide antibiotic produced by Bacillus bacteria that kills gram-positive bacteria by blocking the construction of their cell wall. It is best known as an over-the-counter topical ointment for preventing infection in minor cuts, scrapes, and burns, often combined with neomycin and polymyxin B in "triple antibiotic" products. It is widely available over the counter, but it is also a common cause of allergic skin reactions, and its injectable form was withdrawn over kidney-toxicity concerns.
- Cosmetic & topical Skin & aging
Carnosine
Carnosine is a naturally occurring dipeptide, made of the amino acids beta-alanine and histidine, used in skincare as an antioxidant ingredient. Laboratory and ex-vivo skin studies suggest it can neutralize reactive oxygen species and limit glycation, a process in which sugars stiffen skin proteins, which is the rationale for using it in products aimed at the appearance of aging skin. As of 2026, the evidence for topical carnosine is largely from lab and ex-vivo studies rather than large human appearance trials.